Expert solutions from scientific review and protocol design to biomarker development.
Wearable sensor selection, data analysis and review to optimize data quality and results.
VivoSense human augmented AI reduces variability, providing accurate results.
Optimize biomarker specificity with study context, analysis, and visualization.
Our research recognizes the limitations of standard in-clinic spot check measures, such as the 6-minute walk test. At the 3rd Annual Digital Biomarkers in Clinical Trials Summit hosted by Roche in June 2020, we previewed a novel outcome assessment that uses innovative wearable sensor technology to provide the additional granularity of patient functioning and novel movement and mobility-related endpoints.
We strive to develop novel digital biomarkers from wearable sensors that are analytically robust, clinically meaningful, and provide more comprehensive assessments of real-world measures. Get the details about this novel outcome assessment!
